RhEACH is a technical support and policy translation initiative to amplify rheumatic heart disease control efforts locally, regionally and globally. We aim to identify, describe and disseminate solutions for this neglected disease and to reduce burden on vulnerable populations around the world. As a collaborative organization, we partner with a broad range of stakeholders - including clinicians, other disease communities, academics, funders, governments, industry and people living with RHD - to achieve our common goals. Global control of RF and RHD is eminently achievable. Comprehensive register-based programs have already effectively reduced the burden of RF/RHD at a reasonable cost in disparate geographic settings. The drugs and technology needed for successful control programs date from the 1950s yet remain inaccessible to many in need. Freeing young people from RHD and its complication of heart failure, arrhythmias, stroke and endocarditis could be achieved with existing knowledge.
RhEACH is a founding partner of RHD Action - a coalition of global organizations leading the movement to reduce premature mortality from RHD and contributing to both the World Health Organization 25X25 goal and the World Heart Federation. 25x25<25 goal. The founding partners of RHD Action include Medtronic Foundation, the World Heart Federation and RhEACH. The RHD Action global partners work together to establish a scientific and technical support community available to all countries, draw on this technical knowledge to advocate for policy change for better heart health, support and empower all people living with RHD and to foster multi-sectoral partnerships to support and sustain the global movement. Collectively, RHD Action is committed to work at local, national and global levels to end death and disability from this preventable disease in the world’s most vulnerable communities.